Novartis Ag financial data

Symbol
NVS on NYSE, NVSEF on OTC
Industry
Pharmaceutical Preparations
Location
Lichtstrasse 35, Basel, Switzerland
State of incorporation
Switzerland
Fiscal year end
December 31
Latest financial report
20-F - Q4 2024 - Jan 31, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.98B shares -3.37%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 2.37B USD +2.73%

Balance Sheet

Label TTM Value / Value Unit Change %
Goodwill 24.8B USD +6.06%
Assets 102B USD +2.3%
Liabilities 58.1B USD +9.26%

Popular Metrics

Label TTM Value / Value Unit Change %
Interest Expense 246M USD +13.9%